- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT04709900
Perfusione miocardica da stress TC, riserva di flusso frazionale e angiografia in pazienti con sindromi dolorose toraciche stabili (DYNAMITE)
DYnamic CT Stress Perfusione miocardica, riserva di flusso frazionale CT e angiografia TC coronarica per una strategia di trattamento ottimizzata nei pazienti con sindromi dolorose toraciche sTable
The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Trial design
The DYNAMITE trial is an investigator-initiated, randomised controlled, open-labelled trial conducted in the Capital Region of Copenhagen, Denmark
The following hypothesis will be tested:
- First primary hypothesis: A treatment strategy guided by combined dynamic CT myocardial stress perfusion, FFR-CT and CT coronary angiography improves clinical outcome compared with a conventional management strategy in patients with chronic chest pain syndromes
- Second primary hypothesis: A treatment strategy guided by combined dynamic CT stress myocardial perfusion, FFR-CT and CT coronary angiography results in improved symptom relief compared with a conventional management strategy in patients with chronic chest pain syndromes
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Klaus F Kofoed, MD
- Numero di telefono: 004535458569
- Email: Klaus.kofoed@regionh.dk
Luoghi di studio
-
-
-
Copenhagen, Danimarca, 2100
- Reclutamento
- Department of Cardiology and Radiology, Rigshospitalet, The Heart Center, Capital Region of Copenhagen, University of Copenhagen
-
Contatto:
- Klaus F Kofoed, MD, DmSc
- Numero di telefono: +45 35458569
- Email: Klaus.kofoed@regionh.dk
-
Sub-investigatore:
- Jesper J Linde, MD, Ph.D
-
Sub-investigatore:
- Lars V Køber, MD,DmSc
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Chest pain in patients with clinically suspected or confirmed ischemic heart disease
-
Clinical indication for non-acute coronary evaluation
-
Status of coronary revascularization
-
With previous coronary revascularization - all patients
-
Without previous coronary revascularization
-
Age≥65 years - all patients with chest pain
-
Age>50 - <65 years - typical angina pectoris and at least one cardiovascular risk factor and/or previous myocardial infarction
- Typical angina requiring all 3 criteria present: a) constrictive discomfort in the front of the chest or in the neck, jaw, shoulder or arm, b) precipitated by physical exertion c) relieved by rest or nitrates within 5 min.
- Cardiovascular risk factors: hypertension, diabetes, hypercholesterolemia, current smoking, family history of ischemic heart disease, previous stroke, peripheral artery disease
-
-
Exclusion Criteria:
- Persistent chest pain and signs of ongoing acute myocardial ischemia requiring acute coronary intervention
- Hospitalization and discharge with the confirmed diagnosis acute coronary syndrome (STEMI or NSTEMI) within the last 6 months
- Severe valvular heart disease as primary diagnosis and/or in potential need of percutaneous or surgical valve treatment
- Known severe heart failure (LVEF less than 35%)
- Language, cultural or mental factors preventing the patient from understanding the informed consent form
- Known atrial fibrillation
- Known renal impairment (estimated Glomerular Filtration Rate below <30 ml/min)
- Known x-ray contrast allergy
- Known intolerance to adenosine infusion
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Intervention group
CT angiography, FFR-CT and dynamic CT stress myocardial perfusion guided treatment strategy |
The study intervention team consists of a specialist in Cardiac CT imaging, an invasive cardiologist, a thoracic surgeon and a cardiology nurse specialist. Treatment strategy defined by the study team based on CT findings involve referral for percutaneous coronary intervention, Coronary Artery Bypass surgery and/or initiation of optimal medical therapy, in addition to potential supplementary diagnostic procedures. |
|
Nessun intervento: Standard care group
Evaluation and treatment strategy according to contemporary clinical practice |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Major Adverse Cardiovascular Events
Lasso di tempo: 3 years
|
cardiovascular death, acute myocardial infarction, stroke or hospitalization for heart failure |
3 years
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Individual components of the primary endpoint
Lasso di tempo: 3 years
|
cardiovascular death; acute myocardial infarction; stroke or hospitalization for heart failure |
3 years
|
|
Acute myocardial infarction stratified by subtype
Lasso di tempo: 12 months
|
Subtypes of acute myocardial infarction according to Fourth Universal Definition 2018 |
12 months
|
|
Hospitalization due to unstable angina pectoris, bleeding, pacemaker and/or implantable/cardioverter defibrillator implantation, surgical or percutaneous heart valve treatment
Lasso di tempo: 3 years
|
Cardiovascular hospitalizations |
3 years
|
|
All-cause mortality
Lasso di tempo: 3 years
|
All-cause mortality |
3 years
|
|
All-cause mortality
Lasso di tempo: 10 years
|
Long-term registry based all-cause mortality at 10 years |
10 years
|
|
Number and type of diagnostic tests performed
Lasso di tempo: 12 months
|
Cardiac CT, Exercise ECG, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography |
12 months
|
|
Number of invasive coronary test not leading to coronary revascularization
Lasso di tempo: 12 months
|
number of invasive procedures |
12 months
|
|
Number of coronary revascularization
Lasso di tempo: 3 years
|
Coronary bypass surgery and/or percutaneous coronary intervention |
3 years
|
|
Cumulative iodinated contrast volume
Lasso di tempo: 12 months
|
Cardiac computed tomography, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, invasive optical coherence tomography |
12 months
|
|
Cumulative radiation dose
Lasso di tempo: 12 months
|
Cardiac CT, perfusion Positron Emission Tomography, perfusion Single-photon emission computed tomography, perfusion magnetic resonance, invasive coronary angiography, invasive fractional flow reserve, intravascular ultrasound, optical coherence tomography |
12 months
|
|
Major procedural complications occuring during procedures (invasive, non-invasive or coronary revascularization)
Lasso di tempo: 12 months
|
death, cardiac arrest, cardiac arrhytmia, acute myocardial infarction, stroke, bleeding, unplanned revascularization and any complication requiring and/or prolonging hospitalizaation at least 24 hours |
12 months
|
|
Minor procedural complication specific to type of procedure (invasive, non-invasive or during coronary revascularization)
Lasso di tempo: 12 months
|
Minor procedural complications |
12 months
|
|
Patients diagnosed with non-cardiac disease as likely explanation for symptoms
Lasso di tempo: 12 months
|
non-cardiac diseases causing chest pain |
12 months
|
|
Seattle Angina Questionaire
Lasso di tempo: 3 months and 12 months
|
Seattle Angina Questionaire pre-randomization, 3 months and 12 months after randomization |
3 months and 12 months
|
|
Quality of life by EQ-5D-5L instrument
Lasso di tempo: 3 months and 12 months
|
Quality of life estimated by EQ-5D-5L instrument pre-randomization, 3 months and 12 months after randomization |
3 months and 12 months
|
Collaboratori e investigatori
Investigatori
- Investigatore principale: Klaus F Kofoed, MD, Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
- Dolore
- Manifestazioni neurologiche
- Disturbi cerebrovascolari
- Malattie del cervello
- Malattie del sistema nervoso centrale
- Malattie del sistema nervoso
- Malattie vascolari
- Malattie cardiache
- Arteriosclerosi
- Malattie arteriose occlusive
- Malattia coronarica
- Ischemia miocardica
- Condizioni patologiche, segni e sintomi
- Segni e sintomi
- Ictus
- Arresto cardiaco
- Malattia cardiovascolare
- Disfunsione dell'arteria coronaria
- Dolore al petto
- Tecniche e procedure diagnostiche
- Diagnosi
- Tomografia
- Imaging diagnostico
- Radiografia
- Interpretazione dell'immagine, assistita da computer
- Miglioramento dell'immagine radiografica
- Miglioramento dell'immagine
- Fotografia
- Tomografia, radiografia
- Tomografia, raggi X calcolata
- Imaging multimodale
- Computed Tomography Angiography
Altri numeri di identificazione dello studio
- NNF19OC0057592
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Following publication of the main results of the trial, anonymized data will be made available to other researchers through the Zenodo open data repository.
Periodo di condivisione IPD
Statistical Analysis Plan and study protocol a time of publication
Criteri di accesso alla condivisione IPD
Curated by principle investigator according to contemporary law
Tipo di informazioni di supporto alla condivisione IPD
- STUDIO_PROTOCOLLO
- LINFA
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .